The Australian Research Data Commons (ARDC) Health Studies Australian National Data Asset (HeSANDA) program is building national infrastructure to allow researchers to access and share data from health studies, including clinical trials.
The IMPACCT Trials Coordination Centre (ITCC) will continue to list clinical trials on this page as datasets become available.
Access can be requested via the Health Data Australia catalogue. Search for the ACTRN number in the catalogue to find datasets associated with these trials or email enquiries to hesanda@uts.edu.au.
Read about the HeSANDA program
Ketamine for complex cancer painDOI: 10.58084/xcp3-4d44 A randomised, double-blind, placebo-controlled study of subcutaneous ketamine in the management of cancer pain. | Risperidone and haloperidol in deliriumDOI: 10.58084/c81x-td25 A phase III randomised, double-blind placebo controlled study to compare the effectiveness of oral Risperidone and oral Haloperidol in the management of delirium. |
Megestrol dexamethasone and placebo for anorexiaDOI: 10.58084/pyv7-z724 A randomised, double-blind controlled trial of megestrol acetate, dexamethasone, and placebo in the management of anorexia in people with cancer. | Octreotide for bowel obstructionDOI: 10.58084/fv1e-ac81 A randomised, double-blind, placebo-controlled trial of infusional subcutaneous octreotide in the management of malignant bowel obstruction in people with advanced cancer. |
Sertraline for breathlessnessDOI: 10.58084/hd69-tr47 A randomised, double-blind, multi-site, parallel arm, controlled trial to assess relief of refractory breathlessness comparing oral sertraline and placebo. | Opioids for breathlessnessDOI: 10.58084/7vg4-qk30 A randomised, double-blind, multi-site, parallel arm, controlled trial to assess relief of refractory breathlessness comparing fixed doses of morphine and placebo. |